Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
4.
Hum Mutat ; 22(6): 428-33, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14635101

ABSTRACT

Gene dosage abnormalities account for a significant proportion of the mutations in genes tested in DNA diagnostic laboratories. Detection of these changes has proved a challenge as the methods available to date are time consuming or unreliable. The multiplex ligation-dependent probe assay (MLPA) is a new technique allowing relative quantification of up to 40 different nucleic acid sequences in a single reaction tube. We have evaluated MLPA for potential use in the diagnostic setting against the following criteria: accuracy, reagent cost, hands-on time, reliability, and retests required. A total of 215 UK patients referred for genetic testing on the basis of a family history consistent with autosomal dominant hereditary non-polyposis colorectal cancer (HNPCC or Lynch syndrome) were tested by MLPA. Of these, 12 cases with deletions of one or more exons were identified, six with MLH1 deletions and six with MSH2 deletions. Test failure rates were less than 5% and overall mutation detection sensitivity in this series was increased by approximately 50% by the inclusion of MLPA for an additional testing cost of about 10%. Two novel mutations in MSH2 and 10 novel point mutations in MLH1 were also identified during the course of this study. We conclude that MLPA is a cost effective and robust gene dosage method that can be readily adopted by diagnostic services. Comprehensive mutation scanning for MSH2 and MLH1 is incomplete without gene dosage analysis.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , DNA Mutational Analysis/methods , DNA-Binding Proteins , Gene Deletion , Neoplasm Proteins/genetics , Proto-Oncogene Proteins/genetics , Adaptor Proteins, Signal Transducing , Carrier Proteins , Colorectal Neoplasms, Hereditary Nonpolyposis/pathology , DNA Repair , Exons/genetics , Haplotypes , Humans , MutL Protein Homolog 1 , MutS Homolog 2 Protein , Nuclear Proteins , Point Mutation , Reproducibility of Results , Sensitivity and Specificity
5.
Br J Cancer ; 86(10): 1592-6, 2002 May 20.
Article in English | MEDLINE | ID: mdl-12085209

ABSTRACT

This report describes an individual with a rare choroid plexus papilloma in adulthood (age 29) after earlier having an osteosarcoma (age 22). The results from this study, and others, suggest that it may be advisable to consider the possibility of a germline p53 mutation in adults presenting with choroid plexus tumours. In the current study automated DNA sequencing of genomic DNA detected a novel germline 7 base pair insertion in exon 5 of the p53 gene in this patient. The alteration in frame would produce amino acid substitutions beginning with alanine to glycine at position 161 and a stop codon at position 182 in the mutated protein. Surprisingly two assays of p53 function gave apparently wild-type results on peripheral blood lymphocytes from this individual. These results led us to carry out more detailed functional tests on the mutant protein. The mutant allele was expressed either at very low levels or not at all in phytohaemagglutinin stimulated lymphocytes. Further, the mutant protein was completely non-functional in terms of its ability to transactivate a series of p53-responsive genes (p21(WAF1), bax, PIG3), to transrepress a target gene and to inhibit colony growth in transfected Saos-2 cells. However, surprisingly, data from irradiated peripheral blood lymphocytes and transfected Saos-2 cells, suggested that this truncated, mutant protein retains significant ability to induce apoptosis.


Subject(s)
Bone Neoplasms/genetics , Choroid Plexus Neoplasms/genetics , Codon, Nonsense , Frameshift Mutation , Genes, p53 , Germ-Line Mutation , Mutagenesis, Insertional , Neoplasm Proteins/physiology , Neoplasms, Second Primary/genetics , Osteosarcoma/genetics , Papilloma/genetics , Tumor Suppressor Protein p53/physiology , Adult , Alleles , Amino Acid Substitution , Apoptosis , Base Sequence , Bone Neoplasms/pathology , DNA Mutational Analysis , DNA, Neoplasm/genetics , Exons/genetics , Female , Genetic Predisposition to Disease , Humans , Lymphocytes/pathology , Lymphocytes/radiation effects , Molecular Sequence Data , Neoplasm Proteins/chemistry , Neoplasm Proteins/deficiency , Osteosarcoma/pathology , Pedigree , Recombinant Fusion Proteins/physiology , Saccharomyces cerevisiae/genetics , Transcriptional Activation , Transfection , Tumor Cells, Cultured/pathology , Tumor Stem Cell Assay , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/deficiency
SELECTION OF CITATIONS
SEARCH DETAIL
...